These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29411964)

  • 81. Downregulation of miRNA-31 induces taxane resistance in ovarian cancer cells through increase of receptor tyrosine kinase MET.
    Mitamura T; Watari H; Wang L; Kanno H; Hassan MK; Miyazaki M; Katoh Y; Kimura T; Tanino M; Nishihara H; Tanaka S; Sakuragi N
    Oncogenesis; 2013 Mar; 2(3):e40. PubMed ID: 23552883
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The inhibition of BRAF activity sensitizes chemoresistant human ovarian cancer cells to paclitaxel-induced cytotoxicity and tumor growth inhibition.
    Zhao L; Huang L; Zhang J; Fan J; He F; Zhao X; Wang H; Liu Q; Shi D; Ni N; Wagstaff W; Pakvasa M; Fu K; Tucker AB; Chen C; Reid RR; Haydon RC; Luu HH; Shen L; Qi H; He TC
    Am J Transl Res; 2020; 12(12):8084-8098. PubMed ID: 33437383
    [TBL] [Abstract][Full Text] [Related]  

  • 83. FKA-A NPs enhances PTX-A NPs efficacy to suppress ovarian cancer via regulating Skp2/YAP pathway.
    Li J; Wang R; Liu Y; Wu Y; Han L; Zheng L; Bao Z
    Fundam Clin Pharmacol; 2023 Feb; 37(1):125-136. PubMed ID: 36028983
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Targeted delivery of cancer drug paclitaxel to chordomas tumor cells via an RNA nanoparticle harboring an EGFR aptamer.
    Xiao D; Huang Y; Huang S; Zhuang J; Chen P; Wang Y; Zhang L
    Colloids Surf B Biointerfaces; 2022 Apr; 212():112366. PubMed ID: 35144131
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Fentanyl activates ovarian cancer and alleviates chemotherapy-induced toxicity via opioid receptor-dependent activation of EGFR.
    Xiao K; Zheng Q; Bao L
    BMC Anesthesiol; 2022 Aug; 22(1):268. PubMed ID: 35999506
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Deguelin Restores Paclitaxel Sensitivity in Paclitaxel-Resistant Ovarian Cancer Cells via Inhibition of the EGFR Signaling Pathway.
    Bae S; Bae S; Kim HS; Lim YJ; Kim G; Park IC; So KA; Kim TJ; Lee JH
    Cancer Manag Res; 2024; 16():507-525. PubMed ID: 38827785
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Nanoparticles carrying paclitaxel and anti-miR-221 for breast cancer therapy triggered by ultrasound.
    Zhang L; Ren Z; Lü J; Mo X; Lin J; Li Y; Ma W; Liu P; Shen Y; Zhao Q; Qian L; Cheng X; Yu Z; Zhang B
    Cell Death Discov; 2023 Aug; 9(1):298. PubMed ID: 37582832
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Co-delivery of carboplatin and paclitaxel
    Zhang X; Liu Y; Kim YJ; Mac J; Zhuang R; Wang P
    RSC Adv; 2017 Apr; 7(32):19685-19693. PubMed ID: 28603607
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Inhibition of DUSP6 sensitizes ovarian cancer cells to chemotherapeutic agents via regulation of ERK signaling response genes.
    James NE; Beffa L; Oliver MT; Borgstadt AD; Emerson JB; Chichester CO; Yano N; Freiman RN; DiSilvestro PA; Ribeiro JR
    Oncotarget; 2019 May; 10(36):3315-3327. PubMed ID: 31164954
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Tephrosin Suppresses the Chemoresistance of Paclitaxel-Resistant Ovarian Cancer via Inhibition of FGFR1 Signaling Pathway.
    Kim HS; Bae S; Lim YJ; So KA; Kim TJ; Bae S; Lee JH
    Biomedicines; 2023 Nov; 11(12):. PubMed ID: 38137377
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Combination microRNA-based cellular reprogramming with paclitaxel enhances therapeutic efficacy in a relapsed and multidrug-resistant model of epithelial ovarian cancer.
    Gandham SK; Rao M; Shah A; Trivedi MS; Amiji MM
    Mol Ther Oncolytics; 2022 Jun; 25():57-68. PubMed ID: 35399604
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Role of Survivin in Bladder Cancer: Issues to Be Overcome When Designing an Efficient Dual Nano-Therapy.
    Arista-Romero M; Cascante A; Fornaguera C; Borrós S
    Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834374
    [TBL] [Abstract][Full Text] [Related]  

  • 93.
    Chiu HW; Chang JS; Lin HY; Lee HH; Kuei CH; Lin CH; Huang HM; Lin YF
    J Clin Med; 2018 Oct; 7(10):. PubMed ID: 30301218
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Progress in systemic co-delivery of microRNAs and chemotherapeutics for cancer treatment by using lipid-based nanoparticles.
    He W; Turkeshi A; Li X; Zhang H
    Ther Deliv; 2020 Sep; 11(9):591-603. PubMed ID: 32933403
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Tumor suppressor genes and their underlying interactions in paclitaxel resistance in cancer therapy.
    Xu JH; Hu SL; Shen GD; Shen G
    Cancer Cell Int; 2016; 16():13. PubMed ID: 26900348
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Delivering Combination Chemotherapies and Targeting Oncogenic Pathways via Polymeric Drug Delivery Systems.
    Nair PR
    Polymers (Basel); 2019 Apr; 11(4):. PubMed ID: 30959799
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Cytosolic delivery of the immunological adjuvant Poly I:C and cytotoxic drug crystals
    Du X; Hou Y; Huang J; Pang Y; Ruan C; Wu W; Xu C; Zhang H; Yin L; He W
    Acta Pharm Sin B; 2021 Oct; 11(10):3272-3285. PubMed ID: 34729315
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Photo-controlled release of paclitaxel and model drugs from RNA pyramids.
    Xu C; Li H; Zhang K; Binzel DW; Yin H; Chiu W; Guo P
    Nano Res; 2019 Jan; 12(1):41-48. PubMed ID: 31258852
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Mitochondrion-Directed Nanoparticles Loaded with a Natural Compound and a microRNA for Promoting Cancer Cell Death via the Modulation of Tumor Metabolism and Mitochondrial Dynamics.
    Lo YL; Wang CS; Chen YC; Wang TY; Chang YH; Chen CJ; Yang CP
    Pharmaceutics; 2020 Aug; 12(8):. PubMed ID: 32796618
    [TBL] [Abstract][Full Text] [Related]  

  • 100. New
    Kischkel FC; Eich J; Meyer CI; Weidemüller P; Krapfl J; Yassin-Kelepir R; Job L; Fraefel M; Braicu I; Kopp-Schneider A; Sehouli J; De Wilde RL
    PeerJ; 2017; 5():e3030. PubMed ID: 28265509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.